Latest Ratings for ADMA Date Firm Action From To Nov 2021 Raymond James Upgrades Outperform Strong Buy Nov 2021 Cantor Fitzgerald Initiates Coverage On Overweight Oct 2021 Raymond James Maintains Outperform View More Analyst Ratings for ADMA ...
Read Also
- IFS: Clumsy capital gains reform could ‘harm government’s growth mission’
- The power of bamboo: A renewable resource to combat climate change
- Why smart agriculture is the future of Indian farmer?
- NHAI awards Toll, Operate and Transfer bundle for ₹6,661 crore
- Pro-Bitcoin El Salvador President Nayib Bukele Meets Elon Musk At Tesla's Giga Texas, Hails Billionaire CEO As 'One Of The Great Minds Of Our Time'
- Qualcomm Reportedly Eyes Potential Takeover Of Intel Amid 60% Stock Decline, But Antitrust Concerns Loom
- Impact of extended monsoon and heavy rain on kharif crops
- Tesla's Stock Performance In 2019 And 2024 Shows 'Striking' Similarities, Says Gary Black: Flags This Reason That May Lead To Price Surge In 2025
- Republicans In Damage Control Mode After Mark Robinson's Remarks Spark Concern For Trump Campaign: 'Going To Have An Up-Ballot Effect,' Says GOP Consultant
- SpaceX Pushes Ahead With Fifth Starship Test Flight Preparation Despite No FAA Launch Approvals In Sight
Latest Benzinga
- Pro-Bitcoin El Salvador President Nayib Bukele Meets Elon Musk At Tesla's Giga Texas, Hails Billionaire CEO As 'One Of The Great Minds Of Our Time'
- Qualcomm Reportedly Eyes Potential Takeover Of Intel Amid 60% Stock Decline, But Antitrust Concerns Loom
- Tesla's Stock Performance In 2019 And 2024 Shows 'Striking' Similarities, Says Gary Black: Flags This Reason That May Lead To Price Surge In 2025
- Republicans In Damage Control Mode After Mark Robinson's Remarks Spark Concern For Trump Campaign: 'Going To Have An Up-Ballot Effect,' Says GOP Consultant
- SpaceX Pushes Ahead With Fifth Starship Test Flight Preparation Despite No FAA Launch Approvals In Sight
- JPMorgan CEO Jamie Dimon Calls For Federal Employees To Return To Office, Says Empty Buildings 'Bother' Him: 'I Can't Believe...'
- Here's How Much You Would Have Made Owning Oracle Stock In The Last 5 Years
- In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
- A Closer Look at 10 Analyst Recommendations For Renasant
- Unveiling 4 Analyst Insights On Cathay General